138 related articles for article (PubMed ID: 24345670)
1. First case of T-cell/histiocyte-rich-large B-cell lymphoma presenting with duodenal obstruction.
Köksal AR; Alkim H; Ergun M; Boga S; Bayram M; Alkim C; Eryilmaz OT
Libyan J Med; 2013 Dec; 8(1):22955. PubMed ID: 24345670
[No Abstract] [Full Text] [Related]
2. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of a primary cardiac B-cell lymphoma.
Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
[No Abstract] [Full Text] [Related]
4. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
[No Abstract] [Full Text] [Related]
6. An 82-year-old woman with left upper lobe atelectasis. Diffuse large B-cell lymphoma.
Seeram V; Shujaat A; Jones L; Bajwa A
Chest; 2012 Dec; 142(6):1669-1674. PubMed ID: 23208341
[No Abstract] [Full Text] [Related]
7. Large B-cell non-Hodgkin lymphoma.
Vaseemuddin M; Sam R
Am J Kidney Dis; 2005 Dec; 46(6):A52, e101-2. PubMed ID: 16315353
[No Abstract] [Full Text] [Related]
8. Education and Imaging. Gastroenterology: mesenteric lymphoma with chylous ascites.
Arasawa S; Nakase H; Minami N
J Gastroenterol Hepatol; 2014 Aug; 29(8):1570. PubMed ID: 25073631
[No Abstract] [Full Text] [Related]
9. Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia.
Rossi G; Zecca M; Marchi A; de Stefano P; Sammarchi L; Locatelli F
Br J Haematol; 2003 Jan; 120(2):369-71. PubMed ID: 12542504
[No Abstract] [Full Text] [Related]
10. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
11. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab].
Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S
Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179
[TBL] [Abstract][Full Text] [Related]
12. Intravascular large B cell lymphoma: widespread but not everywhere.
Ponzoni M; Ferreri AJ
Acta Haematol; 2014; 131(1):16-7. PubMed ID: 24021531
[No Abstract] [Full Text] [Related]
13. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Chiappella A; Tucci A; Castellino A; Pavone V; Baldi I; Carella AM; Orsucci L; Zanni M; Salvi F; Liberati AM; Gaidano G; Bottelli C; Rossini B; Perticone S; De Masi P; Ladetto M; Ciccone G; Palumbo A; Rossi G; Vitolo U;
Haematologica; 2013 Nov; 98(11):1732-8. PubMed ID: 23812930
[TBL] [Abstract][Full Text] [Related]
14. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
15. FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma.
Fabisiewicz A; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Siedlecki JA
Leuk Lymphoma; 2011 Aug; 52(8):1604-6. PubMed ID: 21657954
[No Abstract] [Full Text] [Related]
16. Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.
Dabaja BS; Hess K; Shihadeh F; Podoloff DA; Medeiros LJ; Mawlawi O; Arzu I; Oki Y; Hagemeister FB; Fayad LE; Reed VK; Kedir A; Wogan CF; Rodriguez A
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):384-91. PubMed ID: 24721592
[TBL] [Abstract][Full Text] [Related]
17. [Gastric cytomegalovirus infection in a patient with non-Hodgkin's lymphoma].
Hernández-Belmonte A; Amorós-Martínez F; Fernández-García PL; Navarro-López V
Rev Esp Quimioter; 2015 Dec; 28(6):324-5. PubMed ID: 26621179
[No Abstract] [Full Text] [Related]
18. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
[No Abstract] [Full Text] [Related]
19. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
[TBL] [Abstract][Full Text] [Related]
20. Patient with high-grade fever, night sweats, and hepatosplenomegaly.
Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H
J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
